Your browser doesn't support javascript.
loading
Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.
Dutta, Pinaki; Reddy, Kavita S; Rai, Ashutosh; Madugundu, Anil K; Solanki, Hitendra S; Bhansali, Anil; Radotra, Bishan D; Kumar, Narendra; Collier, David; Iacovazzo, Donato; Gupta, Prakamya; Raja, Remya; Gowda, Harsha; Pandey, Akhilesh; Devgun, Jagtar Singh; Korbonits, Márta.
Afiliação
  • Dutta P; Department of Endocrinology, Postgraduate Institution of Medical Education and Research, Chandigarh, India.
  • Reddy KS; Institute of Bioinformatics, International Tech Park, Bangalore, Karnataka, India.
  • Rai A; Department of Translational and Regenerative Medicine, Postgraduate Institution of Medical Education and Research, Chandigarh, India.
  • Madugundu AK; Institute of Genetic Medicine, Division of Proteomics, Mayo Clinic, Rochester, Minnesota.
  • Solanki HS; Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Bhansali A; Center for Individualized Medicine and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Radotra BD; Department of Translational and Regenerative Medicine, Postgraduate Institution of Medical Education and Research, Chandigarh, India.
  • Kumar N; School of Biotechnology, KIIT University, Bhubaneswar, India.
  • Collier D; Department of Endocrinology, Postgraduate Institution of Medical Education and Research, Chandigarh, India.
  • Iacovazzo D; Department of Histopathology, Postgraduate Institution of Medical Education and Research, Chandigarh, India.
  • Gupta P; Department of Radiotherapy, Postgraduate Institution of Medical Education and Research, Chandigarh, India.
  • Raja R; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom.
  • Gowda H; Centre for Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom.
  • Pandey A; Indian Council of Medical Research, New Delhi, India.
  • Devgun JS; Department of Translational and Regenerative Medicine, Postgraduate Institution of Medical Education and Research, Chandigarh, India.
  • Korbonits M; Department of Translational and Regenerative Medicine, Postgraduate Institution of Medical Education and Research, Chandigarh, India.
J Clin Endocrinol Metab ; 104(8): 3539-3544, 2019 08 01.
Article em En | MEDLINE | ID: mdl-31125088
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Adenoma / Peptídeos e Proteínas de Sinalização Intracelular Tipo de estudo: Prognostic_studies Limite: Child, preschool / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Adenoma / Peptídeos e Proteínas de Sinalização Intracelular Tipo de estudo: Prognostic_studies Limite: Child, preschool / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article